Overview

Bosentan in Digital Ulcers

Status:
Completed

Trial end date:
2009-01-22

Target enrollment:

Participant gender:

Summary

The aim of the study is to collect long-term efficacy, tolerability and safety data of bosentan in Systemic Sclerosis (SSc) patients suffering from ischemic digital ulcers (DUs).

Phase:

Phase 3

Details

Lead Sponsor:

Actelion

Treatments:

Bosentan